Company News

NAVABLATOR^®Ablation Catheter and PROMAPPER^®Electrophysiology Catheter Receive NMPA Approval

2020-02-21

In Jan 2020, The own R&NAVABLATOR^® Ablation Catheter and PROMAPPER^® Electrophysiology Catheter (Fix Curve and Deflectable Curve) receive the registration certificate from National Medical Products Administration of China (NMPA).

The First Show of NAVABLATOR^®Ablation Catheters and PROMAPPER^® Electrophysiology Cathetersin the 30th Great Wall International Congress of Cardiology (GW-ICC)

2019-10-13

The 30th Great Wall International Congress of Cardiology was held from Oct 10 - 13, 2019 at China National Convention Center, Beijing, China. During the conference, more than 20 centers demonstrated dozens of surgical demonstrations of complex coronary intervention, arrhythmia intervention and structural heart intervention. And more than 200 hospitals participated in the live demonstration and online broadcast of emergency PCI.NAVABLATOR^? Ablation Catheters and PROMAPPER^? Electrophysiology Catheters received widespread attention in the congress.

“Good tools are prerequisite to the successful execution of a job” --- The Development of Electrophysiology in China

2020-02-21

Cardiac electrophysiology technology plays a very important role in the diagnosis and treatment of arrhythmia, and it is also a very active field. In the first broadcast room of the 30th Great Wall International Congress of Cardiology (GW-ICC), Dr Hong Jiang from Renmin Hospital of Wuhan University, Dr Minglong Chen from Jiangsu Province Hospital, Dr Min Tang from Fuwai Hospital, CAMS&PUMC are talking about the development of Cardiac Electrophysiology in China and interpret the frontier progress of the subject.

Investment and Financing Cooperation Agreement Signature with SALUBRIS

2020-01-09

In 16^th Jan 2018, Sichuan Jinjiang Electronic and Shenzhen Salubris Pharmaceuticals Co., ltd. held an investment and financing signing ceremony and the foundation laying ceremony of "JJET production building".

Electrophysiology Recording System and Cardiac RF Ablation Generator Obtained CE Certificate

2020-01-16

The Electrophysiology System and Cardiac RF Ablation Generator independently developed by JJET obtained CE certificate on Mar. 11, 2015, which was an important milestone for JJET and a solid step to enter the international market.

Launch of the First Domestic 3Ding Cardiac Mapping System

2020-01-16

In 2013, the 3Ding Cardiac Mapping System independently developed by JJET was approved by China Food and Drug Administration(CFDA).

Successful Acquisition of America Medical Equipment Company CARDIMA

2019-04-17

In 18^th Feb 2011, JJET participates in a bankruptcy auction at the U.S. bankruptcy court in Oakland, North California.

The First Demonstration Of 3Ding Mapping System in Gansu Province

2020-02-21

On May 2017, Dr Jing Nie from Tianjing Medical University General Hospital was successful cured a patient in atrial premature originated from left superior pulmonary vein and two patients in premature ventricular contractions from ventricular outflow tracked by 3Ding Mapping System and Catheters RF Ablation. It is the first time of 3Ding Mapping System which is used in Circumferential Pulmonary Vein Isolation in Gansu province.